Profound Medical (NASDAQ:PROF) Earns Hold Rating from Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Profound Medical (NASDAQ:PROF – Free Report) in a report published on Tuesday, MarketBeat Ratings reports. The firm issued a hold rating and a $11.00 price target on the stock. Separately, Raymond James upgraded shares of Profound Medical from an outperform rating to a strong-buy rating and set a […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)
Next post Alliance Resource Partners, L.P. (NASDAQ:ARLP) Major Shareholder Sells $306,900.00 in Stock